SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-072197
Filing Date
2011-08-03
Accepted
2011-08-03 16:06:55
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c18091e10vq.htm 10-Q 792997
2 EXHIBIT 31.1 c18091exv31w1.htm EX-31.1 5825
3 EXHIBIT 31.2 c18091exv31w2.htm EX-31.2 5864
4 EXHIBIT 32.1 c18091exv32w1.htm EX-32.1 2289
5 EXHIBIT 32.2 c18091exv32w2.htm EX-32.2 2356
  Complete submission text file 0000950123-11-072197.txt   7111585

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20110630.xml EX-101.INS 1059488
7 EX-101 SCHEMA DOCUMENT celg-20110630.xsd EX-101.SCH 65388
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20110630_cal.xml EX-101.CAL 88017
9 EX-101 LABELS LINKBASE DOCUMENT celg-20110630_lab.xml EX-101.LAB 590451
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20110630_pre.xml EX-101.PRE 391199
11 EX-101 DEFINITION LINKBASE DOCUMENT celg-20110630_def.xml EX-101.DEF 213080
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 111007045
SIC: 2834 Pharmaceutical Preparations